Research indicates that CYP2C8 and CYP3A5 are prominently expressed in the majority of ovarian tumors, showing higher IHC staining intensity of CYP3A5 and other CYP enzymes in primary ovarian cancer tissues. This evidence concerns the gene CYP3A5 and ovarian carcinoma.